USE OF HEDIS A1C TARGETS IN CHARACTERIZING TREATMENT GOALS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING BASAL INSULIN

被引：0
|
作者：
Oster, G. [1 ]
Moen, D. [2 ]
Yang, T. [3 ]
Dalal, M. [3 ]
Kazemi, M. [3 ]
Sung, J. C. [3 ]
Traylor, L. [3 ]
Sullivan, S. D. [4 ]
机构：
[1] Policy Anal Inc, Brookline, MA USA
[2] MoenMDConsulting, St Paul, MN USA
[3] Sanofi US Inc, Bridgewater, NJ USA
[4] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.407
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB100
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 50 条
  • [31] Factors Associated with Basal Insulin Persistence after Initiation among People with Type 2 Diabetes Mellitus (T2DM)
    Desai, Urvi
    Kabul, Samaneh
    Ivanova, Jasmina I.
    Kirson, Noam Y.
    Cummings, Alice Kate
    Ristovska, Ljubica
    Birnbaum, Howard G.
    Hadjiyianni, Irene
    Duan, Ran
    Cao, Dachuang
    Perez-Nieves, Magaly
    DIABETES, 2015, 64 : A223 - A223
  • [32] Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM)
    Weinzimer, SA
    McKnight, WJ
    Murphy, K
    Jawad, AF
    Celona-Jacobs, N
    Haque, A
    Katz, LEL
    DIABETES, 2001, 50 : A68 - A68
  • [33] CLINICAL EXPERIENCES OF TYPE 2 DIABETES (T2DM) PATIENTS INITIATING ORAL SEMAGLUTIDE
    Dunn, T. J.
    Swift, C.
    Guesnier, A.
    Noone, J.
    Willey, V
    VALUE IN HEALTH, 2022, 25 (07) : S309 - S309
  • [34] Unmet Needs and Treatment Patterns of T2DM Patients with Basal Insulin
    Dalal, Mehul
    Grabner, Michael
    Gidaya, Nicole
    Bieszk, Nella
    Digenio, Andres
    DIABETES, 2014, 63 : A232 - A232
  • [35] Influence of preprandial vs postprandial insulin glulisine on A1C and body weight in patients with type 2 diabetes mellitus (T2DM) receiving basal insulin therapy: A multicenter, randomized, parallel, open-label study
    Wynne, Alan G.
    Nakhle, Samer
    Brusco, O. A.
    Rendell, Marc S.
    Vlajnic, Aleksandra
    Ratner, Robert E.
    DIABETES, 2008, 57 : A722 - A722
  • [36] Treatment Progression and Impact of HbA1C in Type 2 Diabetes (T2DM) Patients
    Dibello, Julia R.
    Levy, Brian
    Mehra, Maneesha
    DIABETES, 2010, 59 : A623 - A624
  • [37] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [39] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [40] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
12345